Mountaingate Capital has announced its exit from its investment in Relevate, a Cincinnati-based healthcare commercialization platform. The partnership began in 2020 and has since grown into a key player in pharma, biotech, medical device, and healthcare organization marketing.

Relevate, founded in 2007 as Healthcare Regional Marketing, continues Kent to lead the sector with a focus on strategic market access and product launch support.

CEO Tim Pantello has driven Relevate’s expansion, while Bruce Rogers, co‑founder and managing director of Mountaingate, praised the collaboration. “It has been tremendously rewarding to support the world‑class management team at Relevate as they executed the plan we collectively envisioned at the outset of our partnership,” Rogers said. “We have no doubt they will continue to set the standard within the pharmaceutical commercialization space and we look forward to following their next phase of growth.”

Houlihan Lokey advised on the transaction, with Latham & Watkins providing legal counsel. The exit marks a milestone for both firms and underscores Relevate’s continued commitment to innovation in the healthcare market.